>> Milestone on COVID-19 super antibody: Celltrion has completed what it considers the “most difficult part” of the process, the construction of a 300-antibody library from blood samples collected from recovered patients; the company is now selecting therapeutic antibody candidates. (from: bioworld.com)

Published 1 week ago

>> Back to view ALL ARTICLES